Biopharma company sells feline weight-loss med for $43MMarch 31, 2020A mirtazapine transdermal ointment, used for the management of weight loss in cats, has just changed pharmaceutical hands in a multimillion dollar deal.
Education Center - SponsoredWhy a one-size-fits-all approach doesn’t work for pet insuranceby • Pawlicy AdvisorAccording to the North American Pet Health Insurance Association (NAPHIA), the combined gross premium of the pet health insurance sector in the U.S. and Canada rose 24 percent from $1.15 billion in 2017 to $1.42 billion by the end of 2018.
Veterinary Hospitals Association partners with Kindred BioscienceJune 28, 2019Veterinary Hospitals Association (VHA) and Kindred Biosciences have struck up a partnership that will bring the biopharmaceutical company’s products into more than 420 VHA-represented clinics.
Kindred Biosciences’ Mirataz commercially available in U.S.May 9, 2018Update: this product is now commercially available in the U.S. Kindred Biosciences Inc. has received approval from the U.S. Food & Drug Administration for Mirataz (mirtazapine transdermal ointment) for the management of weight loss in cats. Mirtazapine, which blocks specific serotonin and histamine receptors that play a role in appetite and nausea, demonstrated a 3.9 percent increase in body weight in cats with unintended weight loss in as little as 14 days, according to San …
